Game-Changing Cancer Breakthroughs: What to Watch in 2025
· Tempus AI, Inc. (NASDAQ: TEM) started 2025 announcing the National Launch of its FDA -approved xT CDx Test, a 648-gene next-generation sequencing test for solid tumor profiling, which includes ...
24/7 Wall St. on MSN12m
4 Ultra-Safe Dividend Giants That Pay More Than the 10-Year US Treasury Note
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and ...